{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:39:08Z","timestamp":1792791548348,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,17]],"date-time":"2027-09-17T00:00:00Z","timestamp":1821139200000},"content-version":"am","delay-in-days":290,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01DA060724-02"],"award-info":[{"award-number":["5R01DA060724-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA057346-04"],"award-info":[{"award-number":["R01DA057346-04"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuropharm.2026.111188","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:55:30Z","timestamp":1789494930000},"page":"111188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The effects of HIV-1 regulatory Tat expression on nicotine dependence in mice"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2893-3445","authenticated-orcid":false,"given":"Alayna","family":"Palamar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2854-1039","authenticated-orcid":false,"given":"Yumna","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0031-7377","authenticated-orcid":false,"given":"Belle","family":"Buzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1868-1257","authenticated-orcid":false,"given":"Sara R.","family":"Nass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5470-5717","authenticated-orcid":false,"given":"Justin L.","family":"Poklis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Whiteaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7886-0332","authenticated-orcid":false,"given":"Kurt F.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Imad Damaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.neuropharm.2026.111188_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax7031","article-title":"Microglia morphology and proinflammatory signaling in the nucleus accumbens during nicotine withdrawal","volume":"5","author":"Adeluyi","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuropharm.2026.111188_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.905330","article-title":"Genotypic differences in the effects of menthol on nicotine intake and preference in mice","volume":"16","author":"Akinola","year":"2022","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111188_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(01)01786-4","article-title":"Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum","volume":"305","author":"Aksenov","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111188_bib4","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/ntr\/ntaa277","article-title":"National estimates of prevalence, time-trend, and correlates of smoking in US people living with HIV (NHANES 1999\u20132016)","volume":"23","author":"Asfar","year":"2021","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.neuropharm.2026.111188_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107669","article-title":"Assessing nicotine dependence using an oral nicotine free-choice paradigm in mice","volume":"157","author":"Bagdas","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111188_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108274","article-title":"Impact of menthol on nicotine intake and preference in mice: concentration, sex, and age differences","volume":"179","author":"Bagdas","year":"2020","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111188_bib7","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/ejp.1618","article-title":"Conditional expression of HIV-1 Tat in the mouse alters the onset and progression of tonic, inflammatory, and neuropathic hypersensitivity in a sex-dependent manner","volume":"24","author":"Bagdas","year":"2020","journal-title":"Eur. J. Pain"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111188_bib8","article-title":"Epidemiology of neuropathic pain: an analysis of prevalence and associated factors in UK Biobank","volume":"8","author":"Baskozos","year":"2023","journal-title":"PAIN Rep."},{"issue":"24","key":"10.1016\/j.neuropharm.2026.111188_bib9","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMra0809890","article-title":"Nicotine addiction","volume":"362","author":"Benowitz","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111188_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151271","article-title":"HIV-1 gp120 and tobacco smoke synergistically disrupt the integrity of the blood-brain barrier","volume":"101","author":"Bhalerao","year":"2022","journal-title":"Eur. J. Cell Biol."},{"issue":"13","key":"10.1016\/j.neuropharm.2026.111188_bib11","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/glia.20708","article-title":"Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 tat transgenic mice","volume":"56","author":"Bruce-Keller","year":"2008","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111188_bib12","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s13365-016-0438-3","article-title":"Expression profile of nicotinic acetylcholine receptor subunits in the brain of HIV-1 transgenic rats given chronic nicotine treatment","volume":"22","author":"Cao","year":"2016","journal-title":"J. Neurovirol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111188_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbr.2011.12.019","article-title":"Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse","volume":"229","author":"Carey","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111188_bib14","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3390\/v16071163","article-title":"HIV persistence, latency, and cure approaches: where are we now?","volume":"16","author":"Chou","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.neuropharm.2026.111188_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2013.00041","article-title":"Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking","volume":"4","author":"Cohen","year":"2013","journal-title":"Front. Psychiatr."},{"issue":"3 Suppl. l","key":"10.1016\/j.neuropharm.2026.111188_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1521\/aeap.2009.21.3_supp.40","article-title":"Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans","volume":"21","author":"Crothers","year":"2009","journal-title":"AIDS Educ. Prev. : Off. Publ. Int. Soc. AIDS Educat."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111188_bib17","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/jpet.103.054908","article-title":"Characterization of spontaneous and precipitated nicotine withdrawal in the mouse","volume":"307","author":"Damaj","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.111188_bib18","article-title":"Use of tobacco and alternative nicotine products among people with HIV: a cross-sectional multicenter survey","author":"De Vito","year":"2025","journal-title":"AIDS Behav."},{"key":"10.1016\/j.neuropharm.2026.111188_bib19","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.1038\/s41598-017-07570-5","article-title":"Chronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with aging","volume":"7","author":"Dickens","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111188_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1037\/0021-843X.117.2.467","article-title":"Pain as a motivator of smoking: effects of pain induction on smoking urge and behavior","volume":"117","author":"Ditre","year":"2008","journal-title":"J. Abnorm. Psychol."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111188_bib21","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.3390\/ijms25073588","article-title":"Methamphetamine enhancement of HIV-1 gp120-Mediated NLRP3 inflammasome activation and resultant proinflammatory responses in rat microglial cultures","volume":"25","author":"Dutta","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111188_bib22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s13365-012-0093-2","article-title":"Prevalence of peripheral neuropathy in antiretroviral therapy na\u00efve HIV-positive patients and the impact on treatment outcomes\u2014A retrospective study from a large urban cohort in Johannesburg, South Africa","volume":"18","author":"Evans","year":"2012","journal-title":"J. Neurovirol."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111188_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.biopsych.2012.09.026","article-title":"Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in HIV-1 Tat transgenic mice","volume":"73","author":"Fitting","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111188_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/jpet.115.226407","article-title":"Morphine tolerance and physical dependence are altered in conditional HIV-1 tat transgenic mice","volume":"356","author":"Fitting","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111188_bib25","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2353\/ajpath.2010.090945","article-title":"Interactive comorbidity between opioid drug abuse and HIV-1 tat","volume":"177","author":"Fitting","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111188_bib26","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2353\/ajpath.2010.090945","article-title":"Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons","volume":"177","author":"Fitting","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2026.111188_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep13864","article-title":"Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice","volume":"5","author":"Fiume","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111188_bib28","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/npp.2011.197","article-title":"Habenular signaling in nicotine reinforcement","volume":"37","author":"Fowler","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111188_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108568","article-title":"Potentiation of (\u03b14)2(\u03b22)3, but not (\u03b14)3(\u03b22)2, nicotinic acetylcholine receptors reduces nicotine self-administration and withdrawal symptoms","volume":"190","author":"Hamouda","year":"2021","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111188_bib30","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1038\/s41380-025-02964-8","article-title":"The neural pathway from the superior subpart of the medial habenula to the interpeduncular nucleus suppresses anxiety","volume":"30","author":"Handa","year":"2025","journal-title":"Mol. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111188_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1471-4159.2001.00396.x","article-title":"HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity","volume":"78","author":"Haughey","year":"2001","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111188_bib32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/cid\/cis933","article-title":"Mortality attributable to smoking among HIV-1\u2013Infected individuals: a nationwide, population-based cohort Study","volume":"56","author":"Helleberg","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111188_bib33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14622200701188919","article-title":"Effects of abstinence from tobacco: valid symptoms and time course","volume":"9","author":"Hughes","year":"2007","journal-title":"Nicotine Tob. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111188_bib34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1124\/jpet.107.132977","article-title":"Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs","volume":"325","author":"Jackson","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111188_bib35","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/QAD.0000000000002815","article-title":"Worldwide relative smoking prevalence among people living with and without HIV","volume":"35","author":"Johnston","year":"2021","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111188_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.jcbfm.9600330","article-title":"HIV-1 gp120 compromises blood\u2013brain barrier integrity and enhance monocyte migration across blood\u2013brain barrier: implication for viral neuropathogenesis","volume":"27","author":"Kanmogne","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111188_bib37","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006916","article-title":"Transcriptional and posttranscriptional regulation of HIV-1 gene expression","volume":"2","author":"Karn","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuropharm.2026.111188_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1477845","article-title":"The impacts of tobacco and nicotine on HIV-1 infection, inflammation, and the blood-brain barrier in the central nervous system","volume":"15","author":"Keane","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111188_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuropharm.2016.06.011","article-title":"The effects of HIV-1 regulatory TAT protein expression on brain reward function, response to psychostimulants and delay-dependent memory in mice","volume":"109","author":"Kesby","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111188_bib40","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbi.2017.05.004","article-title":"HIV-1 TAT protein enhances sensitization to methamphetamine by affecting dopaminergic function","volume":"65","author":"Kesby","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111188_bib41","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0002-9440(10)64304-0","article-title":"Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline","volume":"162","author":"Kim","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111188_bib42","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.micinf.2005.11.014","article-title":"HIV tat and neurotoxicity","volume":"8","author":"King","year":"2006","journal-title":"Microb. Infect."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111188_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1151\/spp021113","article-title":"The neurobiology of opioid dependence: implications for treatment","volume":"1","author":"Kosten","year":"2002","journal-title":"Sci. Practice Perspective."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111188_bib44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/13550280902973952","article-title":"Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains","volume":"15","author":"Kumar","year":"2009","journal-title":"J. Neurovirol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111188_bib45","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s10571-022-01232-5","article-title":"Progressive degeneration and adaptive excitability in dopamine D1 and D2 receptor-expressing striatal neurons exposed to HIV-1 tat and morphine","volume":"43","author":"Lark","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111188_bib46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neulet.2016.12.073","article-title":"HIV-1 Tat disrupts blood-brain barrier integrity and increases phagocytic perivascular macrophages and microglia in the dorsal striatum of transgenic mice","volume":"640","author":"Leibrand","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111188_bib47","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s13365-019-00757-8","article-title":"HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity","volume":"25","author":"Leibrand","year":"2019","journal-title":"J. Neurovirol."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111188_bib48","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.2105\/AJPH.2009.188664","article-title":"Smoking-related health risks among persons with HIV in the strategies for management of antiretroviral therapy clinical trial","volume":"100","author":"Lifson","year":"2010","journal-title":"Am. J. Publ. Health"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111188_bib49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/antiox3020414","article-title":"Oxidative stress is associated with neuroinflammation in animal models of HIV-1 tat neurotoxicity","volume":"3","author":"Louboutin","year":"2014","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111188_bib50","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/vaccines8020208","article-title":"HIV gp120 induces the release of proinflammatory, angiogenic, and lymphangiogenic factors from human lung mast cells","volume":"8","author":"Marone","year":"2020","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111188_bib51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.it.2022.11.003","article-title":"New insights into transcription elongation control of HIV-1 latency and rebound","volume":"44","author":"Mbonye","year":"2023","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.111188_bib52","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3390\/cells10082158","article-title":"HIV-associated apathy\/depression and neurocognitive impairments reflect persistent dopamine deficits","volume":"10","author":"McLaurin","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111188_bib53","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1016\/S2214-109X(17)30170-5","article-title":"Tobacco use among people living with HIV: analysis of data from demographic and health surveys from 28 low-income and middle-income countries","volume":"5","author":"Mdege","year":"2017","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.neuropharm.2026.111188_bib54","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M14-0954","article-title":"Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States","volume":"162","author":"Mdodo","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111188_bib55","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.pbb.2011.03.013","article-title":"Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats","volume":"98","author":"Midde","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111188_bib56","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11481-012-9369-9","article-title":"HIV-1 tat protein decreases dopamine transporter cell surface expression and vesicular monoamine Transporter-2 function in rat striatal synaptosomes","volume":"7","author":"Midde","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111188_bib57","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/glia.23447","article-title":"HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific","volume":"66","author":"Miller","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2026.111188_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2023.100062","article-title":"HIV gp120 impairs nucleus accumbens neuroimmune function and dopamine D3 receptor-mediated inhibition of cocaine seeking in male rats","volume":"5","author":"Namba","year":"2023","journal-title":"Addict. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111188_bib59","article-title":"Chronic HIV-1 Tat exposure alters anterior cingulate cortico-basal ganglia-thalamocortical synaptic circuitry, associated behavioral control, and immune regulation in male mice","volume":"5","author":"Nass","year":"2020","journal-title":"Brain Behav. Immun. Health"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111188_bib60","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/v15030590","article-title":"Depressive-like behavior is accompanied by prefrontal cortical innate immune fatigue and dendritic spine losses after HIV-1 tat and morphine exposure","volume":"15","author":"Nass","year":"2023","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111188_bib61","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/026988110001400305","article-title":"Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia","volume":"14","author":"Nath","year":"2000","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111188_bib62","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/jvi.70.3.1475-1480.1996","article-title":"Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic","volume":"70","author":"Nath","year":"1996","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111188_bib63","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s11481-020-09927-6","article-title":"HIV neuropathogenesis in the presence of a disrupted dopamine system","volume":"15","author":"Nickoloff-Bybel","year":"2020","journal-title":"J. Neuroimmune Pharmacol. : Off. J. Soc. NeuroImmune Pharmacol."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111188_bib64","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1177\/09564624221119305","article-title":"Epidemiology of HIV-associated peripheral neuropathy in people living with human immunodeficiency virus infection in Greece","volume":"33","author":"Nikolaidis","year":"2022","journal-title":"Int. J. STD AIDS"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111188_bib65","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1044-7431(03)00171-4","article-title":"HIV-1 tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain","volume":"24","author":"Pu","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111188_bib66","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jlb.65.4.458","article-title":"Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat","volume":"65","author":"Rappaport","year":"1999","journal-title":"J. Leukoc. Biol."},{"issue":"0","key":"10.1016\/j.neuropharm.2026.111188_bib67","article-title":"Parkinsonism in people with virally suppressed HIV","volume":"0","author":"Shorer","year":"2025","journal-title":"Lancet HIV"},{"key":"10.1016\/j.neuropharm.2026.111188_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.811481","article-title":"HIV-1 gp120 impairs spatial memory through cyclic AMP response element-binding protein","volume":"14","author":"Shrestha","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111188_bib69","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/jpet.120.266023","article-title":"[3H]Dopamine uptake through the dopamine and norepinephrine transporters is decreased in the prefrontal cortex of transgenic mice expressing HIV-1 transactivator of transcription protein","volume":"374","author":"Strauss","year":"2020","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111188_bib70","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0304-3940(95)11940-X","article-title":"Neurotoxic mechanisms of transactivating protein Tat of Maedi-Visna virus","volume":"197","author":"Strijbos","year":"1995","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111188_bib71","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s13365-023-01179-3","article-title":"Disruption of blood\u2013brain barrier: effects of HIV Tat on brain microvascular endothelial cells and tight junction proteins","volume":"29","author":"Sun","year":"2023","journal-title":"J. Neurovirol."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111188_bib72","article-title":"E-Cigarette use among persons with diagnosed HIV in the U.S","volume":"2","author":"Thorne","year":"2022","journal-title":"AJ Focus"},{"key":"10.1016\/j.neuropharm.2026.111188_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114226","article-title":"Persistent sensory changes and sex differences in transgenic mice conditionally expressing HIV-1 Tat regulatory protein","volume":"358","author":"Toma","year":"2022","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111188_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2020.106807","article-title":"Self-control and smoking in a sample of adults living with HIV\/AIDS: a cross-sectional survey","volume":"116","author":"Weinberger","year":"2021","journal-title":"Addict. Behav."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111188_bib75","article-title":"Reduced intraepidermal nerve fibre density, glial activation, and sensory changes in HIV type-1 Tat-expressing female mice: involvement of Tat during early stages of HIV-associated painful sensory neuropathy","volume":"3","author":"Wodarski","year":"2018","journal-title":"Pain Rep."},{"key":"10.1016\/j.neuropharm.2026.111188_bib76","unstructured":"WHO. Epidemiological Fact Sheet: HIV statistics, globally and by WHO region, 2023. HIV Data Stat. 2023."},{"key":"10.1016\/j.neuropharm.2026.111188_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2018.00238","article-title":"Medial habenula-interpeduncular nucleus circuit contributes to anhedonia-like behavior in a rat model of depression","volume":"12","author":"Xu","year":"2018","journal-title":"Front. Behav. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111188_bib78","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.biopsych.2011.07.024","article-title":"Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens","volume":"71","author":"Zhang","year":"2012","journal-title":"Biol. Psychiatry Addict.: Risk Recov."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111188_bib79","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1038\/ncomms7770","article-title":"Increased CRF signalling in a ventral tegmental area-interpeduncular nucleus-medial habenula circuit induces anxiety during nicotine withdrawal","volume":"6","author":"Zhao-Shea","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111188_bib80","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3389\/fmicb.2015.00540","article-title":"Intra-ventral tegmental area HIV-1 Tat1\u201386 attenuates nicotine-mediated locomotor sensitization and alters mesocorticolimbic ERK and CREB signaling in rats","volume":"6","author":"Zhu","year":"2015","journal-title":"Front. Microbiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:54:40Z","timestamp":1792788880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":80,"alternative-id":["S0028390826003631"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111188","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of HIV-1 regulatory Tat expression on nicotine dependence in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111188","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111188"}}